Are interspecies comparisons in the toxicity of centrally acting drugs valid without brain concentrations? A commentary
- 1 February 1995
- journal article
- research article
- Published by Elsevier in Neurochemistry International
- Vol. 26 (2) , 103-110
- https://doi.org/10.1016/0197-0186(94)00104-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brainNeuropharmacology, 1992
- Quantification and mechanism of the fluoxetine and tricyclic antidepressant interactionClinical Pharmacology & Therapeutics, 1992
- Fluoxetine and norfluoxetine are potent inhibitors of P450IID6‐the source of the sparteine/debrisoquine oxidation polymorphism [letter]British Journal of Clinical Pharmacology, 1991
- Study of human urinary metabolism of fenfluramine using gas chromatography—mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1991
- A new method for determining allowable daily intakes*1Fundamental and Applied Toxicology, 1984
- Regulatory history and experimental support of uncertainty (safety) factorsRegulatory Toxicology and Pharmacology, 1983
- Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1982
- Kinetics of fenfluramine isomers in the ratEuropean Journal of Drug Metabolism and Pharmacokinetics, 1981
- The Current Status of Attempts to Predict Species Differences in Drug MetabolismDrug Metabolism Reviews, 1981
- Comparison of the time course of the anorectic effect of fenfluramine and amphetamine with drug levels in bloodJournal of Pharmacy and Pharmacology, 1975